Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1984 1
1990 2
1991 7
1992 2
1993 3
1994 1
1995 3
1996 5
1997 3
1998 2
1999 6
2000 6
2001 5
2002 7
2003 4
2004 10
2005 4
2006 9
2007 14
2008 7
2009 5
2010 5
2011 17
2012 18
2013 13
2014 13
2015 10
2016 5
2017 5
2018 9
2019 4
2020 5
2021 3
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.
Herrera AF, Chen L, Nieto Y, Holmberg L, Johnston P, Mei M, Popplewell L, Armenian S, Cao T, Farol L, Sahebi F, Spielberger R, Chen R, Nademanee A, Puverel S, Nwangwu M, Lee P, Song J, Skarbnik A, Kennedy N, Peters L, Rosen ST, Kwak LW, Forman SJ, Feldman T. Herrera AF, et al. Among authors: kwak lw. Lancet Haematol. 2023 Jan;10(1):e14-e23. doi: 10.1016/S2352-3026(22)00318-0. Epub 2022 Nov 17. Lancet Haematol. 2023. PMID: 36403579 Clinical Trial.
Targeting myeloid-derived suppressor cells for cancer immunotherapy.
Liu Y, Wei G, Cheng WA, Dong Z, Sun H, Lee VY, Cha SC, Smith DL, Kwak LW, Qin H. Liu Y, et al. Among authors: kwak lw. Cancer Immunol Immunother. 2018 Aug;67(8):1181-1195. doi: 10.1007/s00262-018-2175-3. Epub 2018 May 31. Cancer Immunol Immunother. 2018. PMID: 29855694 Review.
Lymphomas.
Kwak LW, DeVita VT Jr, Longo DL. Kwak LW, et al. Cancer Chemother Biol Response Modif. 1994;15:413-70. Cancer Chemother Biol Response Modif. 1994. PMID: 7779591 Review. No abstract available.
Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Godfrey J, Mei M, Chen L, Song JY, Bedell V, Budde E, Armenian S, Puverel S, Nikolaenko L, Chen R, Daniels S, Kennedy N, Peters L, Rosen ST, Forman SJ, Popplewell LL, Kwak LW, Herrera AF. Godfrey J, et al. Among authors: kwak lw. Haematologica. 2024 Feb 1;109(2):533-542. doi: 10.3324/haematol.2023.283002. Haematologica. 2024. PMID: 37470137 Free PMC article. Clinical Trial.
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
Kambhampati S, Saumoy M, Schneider Y, Serrao S, Solaimani P, Budde LE, Mei MG, Popplewell LL, Siddiqi T, Zain J, Forman SJ, Kwak LW, Rosen ST, Danilov AV, Herrera AF, Thiruvengadam NR. Kambhampati S, et al. Among authors: kwak lw. Blood. 2022 Nov 10;140(19):2024-2036. doi: 10.1182/blood.2022016747. Blood. 2022. PMID: 35914220 Free PMC article.
Therapeutic vaccine for lymphoma.
Lee ST, Neelapu SS, Kwak LW. Lee ST, et al. Among authors: kwak lw. Yonsei Med J. 2007 Feb 28;48(1):1-10. doi: 10.3349/ymj.2007.48.1.1. Yonsei Med J. 2007. PMID: 17326239 Free PMC article. Review.
Models for lymphoma.
Biragyn A, Kwak LW. Biragyn A, et al. Among authors: kwak lw. Curr Protoc Immunol. 2002 Feb;Chapter 20:20.6.1-20.6.30. doi: 10.1002/0471142735.im2006s46. Curr Protoc Immunol. 2002. PMID: 18432878
Immunotherapy of multiple myeloma.
Ruffini PA, Kwak LW. Ruffini PA, et al. Among authors: kwak lw. Semin Hematol. 2001 Jul;38(3):260-7. doi: 10.1016/s0037-1963(01)90018-6. Semin Hematol. 2001. PMID: 11486314 Review.
205 results